Yair Feld

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Urethral Treatment. Top assignees: Proarc Medical Ltd., Genegrafts Ltd., Corassist Cardiovascular Ltd.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yair Feld. Retrieved from https://idiyas.com/inventor/yair-feld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 73.3

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 212(Granted Patents)

Company Filing History:

Corassist Cardiovascular Ltd.

Paragate Medical Ltd.

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Urethral Treatment

Transcatheter Valve

Heart Function

Peritoneal Dialysis

Nucleic Acids

Electrophysiology

Implantable Devices

Medical Devices

Cardiac Devices

Polynucleotides

Polypeptides

Excitable Tissues

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673192 - Devices for urethral treatment (2026-07-07),

2. 12296123 - Methods and devices for urethral treatment (2025-05-13),

3. 11925376 - Methods and devices for urethral treatment (2024-03-12),

4. 11903832 - Transcatheter artificial cusp for valve insufficiency (2024-02-20),

5. 11724076 - Methods and devices for urethral treatment (2023-08-15),

6. 10583237 - Continuous implantable peritoneal dialysis (2020-03-10),

7. 10406333 - Methods and devices for urethral treatment (2019-09-10),

8. 10035005 - Devices for urethral treatment (2018-07-31),

9. 8382653 - Method and system for improving diastolic function of the heart (2013-02-26),

10. 8101736 - Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same (2012-01-24),

11. 8007779 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2011-08-30),

12. 7993258 - In-vivo method and device for improving diastolic function of the left ventricle (2011-08-09),

13. 7491385 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2009-02-17),

14. 7294333 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2007-11-13),

15. 7186210 - In-vivo method and device for improving diastolic function of the left ventricle (2007-03-06),

Title: The Innovative Journey of Yair Feld

Introduction: Yair Feld, a talented inventor hailing from Haifa, Israel, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Yair Feld's latest patents include a cutting-edge software application for optimizing energy consumption in smart homes and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: Throughout his illustrious career, Yair Feld has been recognized for his innovative spirit and problem-solving skills. He has received multiple awards for his inventions, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Yair Feld has collaborated with leading research institutions and tech companies to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible products that have the potential to improve lives.

Conclusion: Yair Feld's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire the next generation of innovators to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.